HomeAboutRankingsData Sources
Β© 2026 GeneE
🧬
GeneE
10 sources retrieved Β· Most recent: April 2026 Β· Index updated 14 days ago
β“˜GeneE is for informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment.
FIG4
FIG4 phosphoinositide 5-phosphatase
Chromosome 6 Β· 6q21
NCBI Gene: 9896Ensembl: ENSG00000112367.13HGNC: HGNC:16873UniProt: Q92562
64PubMed Papers
24Diseases
0Drugs
125Pathogenic Variants
RESEARCH IMPACT
Variant-Rich
CLINICAL
OMIM Disease Gene
DATA QUALITY
βœ“ Experimental GO Evidenceβœ“ Swiss-Prot Reviewed
endosome membrane1-phosphatidyl-1D-myo-inositol 3,5-bisphosphate metabolic processprotein bindingphosphatidylinositol dephosphorylationYunis-Varon syndromeCharcot-Marie-Tooth disease type 4Jamyotrophic lateral sclerosis type 11bilateral parasagittal parieto-occipital polymicrogyria
✦AI Summary

FIG4 (Factor-Induced Gene 4) encodes a dual specificity phosphoinositide 5-phosphatase that plays a critical role in phospholipid metabolism and cellular membrane trafficking 1. The enzyme functions as part of a regulatory complex with PIKfyve and Vac14 to control both synthesis and turnover of phosphatidylinositol 3,5-bisphosphate (PI(3,5)P2), catalyzing its dephosphorylation to phosphatidylinositol 3-phosphate while also stimulating PIKfyve's lipid kinase activity 1. FIG4 is essential for normal vesicle trafficking and lysosomal biogenesis, with deficiency leading to abnormal lysosomal storage in neurons 23. Mutations in FIG4 cause multiple autosomal recessive neurological disorders, including Charcot-Marie-Tooth disease type 4J (CMT4J), characterized by motor delay, distal muscle weakness, and both motor and sensory neuropathy 4. Additional FIG4-associated conditions include amyotrophic lateral sclerosis, Yunis-Varon syndrome, and in some cases parkinsonism when specific mutations like I41T are present 5. The clinical manifestations often include cognitive deficits, respiratory difficulties, and nonuniform nerve conduction abnormalities 4. FIG4 deficiency represents a form of lysosomal storage disorder affecting primarily nervous system function, highlighting the critical importance of phosphoinositide signaling in neuronal health 26.

Sources cited
1
FIG4 functions in a complex with PIKfyve and Vac14 to regulate PI(3,5)P2 metabolism
PMID: 35584589
2
FIG4 deficiency causes lysosomal storage abnormalities in neurons
PMID: 23165282
3
FIG4 is required for normal vesicle trafficking and lysosomal biogenesis
PMID: 29400714
4
Clinical characteristics of CMT4J include motor delay, muscle weakness, and respiratory/cognitive deficits
PMID: 39133880
5
Specific FIG4 mutations like I41T can cause parkinsonism in addition to CMT4J
PMID: 39457468
6
FIG4 deficiency is part of congenital disorders of autophagy affecting neuronal development and maintenance
PMID: 34130600
Disease Associationsβ“˜24
Yunis-Varon syndromeOpen Targets
0.83Strong
Charcot-Marie-Tooth disease type 4JOpen Targets
0.82Strong
amyotrophic lateral sclerosis type 11Open Targets
0.75Strong
bilateral parasagittal parieto-occipital polymicrogyriaOpen Targets
0.71Strong
Charcot-Marie-Tooth diseaseOpen Targets
0.60Moderate
Charcot-Marie-Tooth disease type 4Open Targets
0.56Moderate
genetic disorderOpen Targets
0.55Moderate
familial amyotrophic lateral sclerosisOpen Targets
0.54Moderate
bilateral polymicrogyriaOpen Targets
0.53Moderate
Joubert syndrome and related disordersOpen Targets
0.52Moderate
amyotrophic lateral sclerosisOpen Targets
0.46Moderate
LeukoencephalopathyOpen Targets
0.37Weak
neurodegenerative diseaseOpen Targets
0.34Weak
Epileptic encephalopathy with global cerebral demyelinationOpen Targets
0.33Weak
gestational diabetesOpen Targets
0.29Weak
COVID-19Open Targets
0.27Weak
Abnormality of the skeletal systemOpen Targets
0.27Weak
MicropenisOpen Targets
0.27Weak
Penile hypospadiasOpen Targets
0.27Weak
Severe global developmental delayOpen Targets
0.27Weak
Amyotrophic lateral sclerosis 11UniProt
Charcot-Marie-Tooth disease, demyelinating, type 4JUniProt
Polymicrogyria, bilateral temporooccipitalUniProt
Yunis-Varon syndromeUniProt
Pathogenic Variants125
NM_014845.6(FIG4):c.122T>C (p.Ile41Thr)Pathogenic
Charcot-Marie-Tooth disease type 4J|not provided|Amyotrophic lateral sclerosis type 11|Charcot-Marie-Tooth disease type 4|Yunis-Varon syndrome;Charcot-Marie-Tooth disease type 4J|Amyotrophic lateral sclerosis|Yunis-Varon syndrome;Charcot-Marie-Tooth disease type 4J;Bilateral parasagittal parieto-occipital polymicrogyria;Amyotrophic lateral sclerosis type 11|Yunis-Varon syndrome|Bilateral parasagittal parieto-occipital polymicrogyria|Inborn genetic diseases|FIG4-related disorder
β˜…β˜…β˜†β˜†2026β†’ Residue 41
NM_014845.6(FIG4):c.547C>T (p.Arg183Ter)Pathogenic
Charcot-Marie-Tooth disease type 4J|Amyotrophic lateral sclerosis type 11|not provided|Charcot-Marie-Tooth disease type 4|Amyotrophic lateral sclerosis|FIG4-related disorder
β˜…β˜…β˜†β˜†2025β†’ Residue 183
NM_014845.6(FIG4):c.1141C>T (p.Arg381Ter)Pathogenic
Charcot-Marie-Tooth disease type 4J|Inborn genetic diseases|Charcot-Marie-Tooth disease type 4|not provided|FIG4-related disorder|Yunis-Varon syndrome
β˜…β˜…β˜†β˜†2025β†’ Residue 381
NM_014845.6(FIG4):c.2467C>T (p.Gln823Ter)Pathogenic
not provided|Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease type 4J|Yunis-Varon syndrome|Charcot-Marie-Tooth disease type 4
β˜…β˜…β˜†β˜†2025β†’ Residue 823
NM_014845.6(FIG4):c.262C>T (p.Arg88Ter)Pathogenic
Amyotrophic lateral sclerosis type 11|Charcot-Marie-Tooth disease type 4J|Charcot-Marie-Tooth disease type 4
β˜…β˜…β˜†β˜†2025β†’ Residue 88
NM_014845.6(FIG4):c.2299dup (p.Glu767fs)Pathogenic
Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease type 4|Inborn genetic diseases|not provided|Charcot-Marie-Tooth disease type 4J
β˜…β˜…β˜†β˜†2025β†’ Residue 767
NM_014845.6(FIG4):c.759del (p.Phe254fs)Pathogenic
Charcot-Marie-Tooth disease type 4J|Amyotrophic lateral sclerosis type 11|Charcot-Marie-Tooth disease type 4|not provided|Charcot-Marie-Tooth disease
β˜…β˜…β˜†β˜†2025β†’ Residue 254
NM_014845.6(FIG4):c.877-2A>CPathogenic
Charcot-Marie-Tooth disease|not provided|Charcot-Marie-Tooth disease type 4|Inborn genetic diseases|FIG4-related disorder|Charcot-Marie-Tooth disease type 4J
β˜…β˜…β˜†β˜†2025
NM_014845.6(FIG4):c.2459+1G>APathogenic
not provided|Inborn genetic diseases|Charcot-Marie-Tooth disease type 4|Charcot-Marie-Tooth disease type 4J|FIG4-related disorder
β˜…β˜…β˜†β˜†2025
NM_014845.6(FIG4):c.737G>A (p.Trp246Ter)Pathogenic
not provided|Amyotrophic lateral sclerosis type 11;Bilateral parasagittal parieto-occipital polymicrogyria;Charcot-Marie-Tooth disease type 4J;Yunis-Varon syndrome|Charcot-Marie-Tooth disease type 4|Inborn genetic diseases|FIG4-related disorder|Charcot-Marie-Tooth disease type 4J
β˜…β˜…β˜†β˜†2025β†’ Residue 246
NM_014845.6(FIG4):c.793C>T (p.Arg265Ter)Pathogenic
not provided|Charcot-Marie-Tooth disease type 4|Inborn genetic diseases|Charcot-Marie-Tooth disease type 4J
β˜…β˜…β˜†β˜†2025β†’ Residue 265
NM_014845.6(FIG4):c.1373dup (p.Leu458fs)Pathogenic
not provided|Charcot-Marie-Tooth disease type 4|Charcot-Marie-Tooth disease|Inborn genetic diseases|Charcot-Marie-Tooth disease type 4J
β˜…β˜…β˜†β˜†2025β†’ Residue 458
NM_014845.6(FIG4):c.1666dup (p.Thr556fs)Pathogenic
Charcot-Marie-Tooth disease type 4|not provided|Charcot-Marie-Tooth disease type 4J|FIG4-related disorder
β˜…β˜…β˜†β˜†2025β†’ Residue 556
NM_014845.6(FIG4):c.1447C>T (p.Arg483Ter)Pathogenic
not provided|Charcot-Marie-Tooth disease type 4
β˜…β˜…β˜†β˜†2025β†’ Residue 483
NM_014845.6(FIG4):c.1294C>T (p.Arg432Ter)Pathogenic
Charcot-Marie-Tooth disease type 4|FIG4-related disorder
β˜…β˜…β˜†β˜†2024β†’ Residue 432
NM_014845.6(FIG4):c.831_838del (p.Lys278fs)Pathogenic
Yunis-Varon syndrome|not provided|Charcot-Marie-Tooth disease type 4|Bilateral parasagittal parieto-occipital polymicrogyria|Inborn genetic diseases|Charcot-Marie-Tooth disease type 4J
β˜…β˜…β˜†β˜†2024β†’ Residue 278
NM_014845.6(FIG4):c.1749_1750+7delLikely pathogenic
Charcot-Marie-Tooth disease type 4|Inborn genetic diseases
β˜…β˜…β˜†β˜†2024
NM_014845.6(FIG4):c.1949-10T>GPathogenic
Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease type 4|See cases|not provided
β˜…β˜…β˜†β˜†2024
NM_014845.6(FIG4):c.1948+1G>ALikely pathogenic
Charcot-Marie-Tooth disease type 4|not provided
β˜…β˜…β˜†β˜†2024
NM_014845.6(FIG4):c.2247dup (p.Ser750fs)Pathogenic
Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease type 4|Amyotrophic lateral sclerosis type 11;Bilateral parasagittal parieto-occipital polymicrogyria;Charcot-Marie-Tooth disease type 4J;Yunis-Varon syndrome
β˜…β˜…β˜†β˜†2024β†’ Residue 750
View on ClinVar β†—
Related Genes
PIK3C3Protein interaction93%MTMR3Protein interaction93%MTMR14Protein interaction91%ALS2Protein interaction91%MTMR8Protein interaction91%FUSProtein interaction89%
Tissue Expression6 tissues
Brain
100%
Lung
29%
Bone Marrow
27%
Ovary
24%
Heart
23%
Liver
15%
Gene Interaction Network
Click a node to explore
FIG4PIK3C3MTMR3MTMR14ALS2MTMR8FUS
PROTEIN STRUCTURE
Preparing viewer…
PDB7K1W Β· 5.10 Γ… Β· EM
View on RCSB β†—
Constraintβ“˜
LOEUFβ“˜
0.97LoF Tolerant
pLIβ“˜
0.00Tolerant
Observed/Expected LoF0.78 [0.63–0.97]
RankingsWhere FIG4 stands among ~20K protein-coding genes
  • #7,263of 20,598
    Most Researched64
  • #629of 5,498
    Most Pathogenic Variants125 Β· top quartile
  • #9,152of 17,882
    Most Constrained (LOEUF)0.97
Genes detectedFIG4
Sources retrieved10 papers
Response timeβ€”
πŸ“„ Sources
10β–Ό
1
A 20-year Clinical and Genetic Neuromuscular Cohort Analysis in Lebanon: An International Effort.
PMID: 34602496
J Neuromuscul Dis Β· 2022
1.00
2
Haploinsufficiency leads to neurodegeneration in C9ORF72 ALS/FTD human induced motor neurons.
PMID: 29400714
Nat Med Β· 2018
0.90
3
FIG4-Related Parkinsonism and the Particularities of the I41T Mutation: A Review of the Literature.
PMID: 39457468
Genes (Basel) Β· 2024
0.80
4
The spectrum of neurodevelopmental, neuromuscular and neurodegenerative disorders due to defective autophagy.
PMID: 34130600
Autophagy Β· 2022
0.70
5
The allelic spectrum of Charcot-Marie-Tooth disease in over 17,000 individuals with neuropathy.
PMID: 25614874
Mol Genet Genomic Med Β· 2014
0.60